Vertiv Holdings Co·4

Mar 2, 8:01 PM ET

COTE DAVID M 4

4 · Vertiv Holdings Co · Filed Mar 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Vertiv (VRT) Executive Chairman David Cote Sells 40,000 Shares

What Happened
David M. Cote, Executive Chairman and Director of Vertiv Holdings Co (VRT), sold 40,000 shares in open-market disposals on February 26, 2026 for total proceeds of $10,211,593 (about $255.29 per share on average). The trades occurred in multiple tranches at prices roughly between $250.06 and $258.93 per share. The filing indicates some of the sales were undertaken on behalf of the Reporting Person’s spouse.

Key Details

  • Transaction date: February 26, 2026; Form 4 filed March 2, 2026 (filed within the required two business days).
  • Total shares sold: 40,000; Total proceeds: $10,211,593; average price ≈ $255.29/share.
  • Price range across tranches: $250.06 – $258.93. Weighted-average prices reported by tranche: $250.23, $252.19, $253.38, $254.39, $255.33, $256.42, $257.45, $258.26.
  • Sales executed on behalf of the Reporting Person’s spouse (footnote F1); the filing also references securities held directly by the spouse (F3).
  • The filing discloses multiple outstanding option grants and vesting schedules (F11–F18) and notes options held in trusts where Mr. Cote is trustee (F19, F20); those options remain unexercised as of the filing.
  • Shares owned after the transactions are not specified in the provided excerpt of the Form 4.

Context
These were open‑market sales (disposals), which are common for liquidity, diversification, or household-level planning and do not, by themselves, indicate management’s view of the company’s prospects. The Form 4 lists substantial outstanding option grants and trust holdings, so Mr. Cote retains derivative exposure to Vertiv even after these sales.

Insider Transaction Report

Form 4
Period: 2026-02-26
COTE DAVID M
DirectorExecutive Chairman
Transactions
  • Sale

    Class A Common Stock

    [F1][F2][F3]
    2026-02-26$250.23/sh2,124$531,48960,134.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F4][F3]
    2026-02-26$252.19/sh5,122$1,291,71755,012.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F5][F3]
    2026-02-26$253.38/sh5,732$1,452,37449,280.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F6][F3]
    2026-02-26$254.39/sh3,301$839,74145,979.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F7][F3]
    2026-02-26$255.33/sh2,833$723,35043,146.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F8][F3]
    2026-02-26$256.42/sh8,437$2,163,41634,709.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F9][F3]
    2026-02-26$257.45/sh7,518$1,935,50927,191.03 total(indirect: See Footnote)
  • Sale

    Class A Common Stock

    [F1][F10][F3]
    2026-02-26$258.26/sh4,933$1,273,99722,258.03 total(indirect: See Footnote)
Holdings
  • Stock Option

    [F11][F19]
    (indirect: See Footnote)
    Exercise: $12.05Exp: 2030-02-07Class A Common Stock (115,942 underlying)
    115,942
  • Stock Option

    [F12][F19]
    (indirect: See Footnote)
    Exercise: $20.56Exp: 2031-02-04Class A Common Stock (115,942 underlying)
    115,942
  • Stock Option

    [F13][F19]
    (indirect: See Footnote)
    Exercise: $11.50Exp: 2032-03-03Class A Common Stock (86,956 underlying)
    86,956
  • Stock Option

    [F14][F20]
    (indirect: See Footnote)
    Exercise: $11.50Exp: 2032-03-03Class A Common Stock (28,986 underlying)
    28,986
  • Stock Option

    [F15][F19]
    (indirect: See Footnote)
    Exercise: $15.84Exp: 2033-03-07Class A Common Stock (25,000 underlying)
    25,000
  • Stock Option

    [F16][F20]
    (indirect: See Footnote)
    Exercise: $15.84Exp: 2033-03-07Class A Common Stock (75,000 underlying)
    75,000
  • Stock Option

    [F17][F20]
    (indirect: See Footnote)
    Exercise: $72.09Exp: 2034-03-07Class A Common Stock (50,000 underlying)
    50,000
  • Stock Option

    [F18][F20]
    (indirect: See Footnote)
    Exercise: $85.04Exp: 2035-03-07Class A Common Stock (46,012 underlying)
    46,012
Footnotes (20)
  • [F1]The Reporting Person undertook sales of the securities on behalf of the Reporting Person's spouse.
  • [F10]The trade was executed in a series of transactions with a price range of $257.96 to $258.93, inclusive, with a weighted average price of $258.26.
  • [F11]Consists of 115,942 stock options granted on February 7, 2020, which vested as to 28,985 on February 7, 2021, 28,986 on February 7, 2022, 28,985 on February 7, 2023, and 28,986 on February 7, 2024.
  • [F12]Consists of 115,942 stock options granted on February 4, 2021, which vested as to 28,986 on each of February 4, 2022 and February 4, 2023, 28,985 on February 4, 2024, and 28,985 on February 4, 2025.
  • [F13]Consists of 86,956 stock options granted on March 3, 2022, which vested as to 28,985 on each of March 3, 2023 and March 3, 2024, and 28,986 on March 3, 2025.
  • [F14]Consists of 28,986 stock options granted on March 3, 2022, which will vest as to 28,986 on March 3, 2026.
  • [F15]Consists of 25,000 stock options granted on March 7, 2023, which vested as to 25,000 on March 15, 2024.
  • [F16]Consists of 75,000 stock options granted on March 7, 2023, which vested as to 25,000 on March 15, 2025, and which will vest as to 25,000 on each of March 15, 2026 and March 15, 2027.
  • [F17]Consists of 50,000 stock options granted on March 7, 2024, which vested as to 12,500 on March 15, 2025, and which will vest as to 12,500 on each of March 15, 2026, March 15, 2027 and March 15, 2028.
  • [F18]Consists of 46,012 stock options granted on March 7, 2025, which will vest as to 11,503 on each of March 15, 2026, March 15, 2027, March 15, 2028 and March 15, 2029.
  • [F19]Reflects securities held directly by a grantor retained annuity trust (the "trust"), of which the Reporting Person is the trustee and annuitant and over which securities the Reporting Person maintains indirect beneficial ownership. As of the date of this Form 4, these options have not been exercised and remain held by the trust.
  • [F2]The trade was executed in a series of transactions with a price range of $250.06 to $250.68, inclusive, with a weighted average price of $250.23. The reporting person undertakes to provide to Vertiv Holdings Co, any security holder of Vertiv Holdings Co, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 10, inclusive.
  • [F20]Reflects securities held directly by David M. Cote 2018 Revocable Trust, of which the Reporting Person is the trustee. As of the date of this Form 4, these options have not been exercised and remain held by David M. Cote 2018 Revocable Trust.
  • [F3]Reflects securities held directly by the Reporting Person's spouse.
  • [F4]The trade was executed in a series of transactions with a price range of $251.80 to $252.76, inclusive, with a weighted average price of $252.19.
  • [F5]The trade was executed in a series of transactions with a price range of $252.80 to $253.79, inclusive, with a weighted average price of $253.38.
  • [F6]The trade was executed in a series of transactions with a price range of $253.82 to $254.81, inclusive, with a weighted average price of $254.39.
  • [F7]The trade was executed in a series of transactions with a price range of $254.85 to $255.81, inclusive, with a weighted average price of $255.33.
  • [F8]The trade was executed in a series of transactions with a price range of $255.91 to $256.89, inclusive, with a weighted average price of $256.42.
  • [F9]The trade was executed in a series of transactions with a price range of $256.96 to $257.95, inclusive, with a weighted average price of $257.45.
Signature
/s/ Eric Broxterman, as attorney-in-fact|2026-03-02

Documents

1 file
  • 4
    es260745120_4-cote.xmlPrimary

    OWNERSHIP DOCUMENT